Studies presented at the 2018 San Antonio Breast Cancer Symposium investigate when patients with early-stage breast cancer or precancerous breast conditions benefit from receiving less intense treatment.
by Kate Yandell
Medical oncologist and sarcoma specialist George D. Demetri explains the significance of the recent approval of the oral drug Vitrakvi based on tumor genetics.
by Anna Azvolinsky
Scientific meeting emphasizes the importance of patient advocates in helping researchers to reduce cancer health disparities.
by Marci A. Landsmann
Medical oncologist Gabrielle Rocque explains the role of clinical practice guidelines in breast cancer care.
Analysis suggests states that opted for Medicaid expansion had higher use of hormone therapy for breast cancer patients.
National Cancer Institute director Norman “Ned” Sharpless describes the challenge and opportunity of studying cancer disparities.
Through the Angiosarcoma Project, researchers are partnering with patients to learn about a rare cancer.
by Ashley P. Taylor
The human papillomavirus vaccine can significantly cut recipients’ risk of several types of cancer. So why are vaccination rates relatively low in the U.S.?
by Brad Jones
The multiple tumors in patients with metastatic disease share key genetic traits, a sequencing study shows.
Forward Look
Computational and molecular biologist Sourav Bandyopadhyay discusses new ways to think about chemotherapy.
by Sue Rochman
Patients with head and neck cancer often face physical, social and emotional issues that can add to existing mental health problems or give rise to new ones.
by Cheryl Platzman Weinstock
A caregiver offers tips for staying on top of appointments and test results when a loved one is receiving care from multiple providers.
by Tara Rosenzweig
Steven Rosenberg explains his work trying to treat cancer with tumor infiltrating lymphocytes.
The U.S. Food and Drug Administration approves three new treatments for acute myeloid leukemia.
Researchers investigate how the microbiome affects immune response patterns in colorectal tumors.
Janet Freeman-Daily: On Lung Cancer and Blame
donate to the AACR